Harmony Biosciences Holdings, Inc. has grown revenue 24% a year over three years and 35% a year over five, with earnings per share compounding at −7.0%. Revenue growth, 3-year annual rate: +24% (Biotechnology median +21%). Revenue growth, 5-year rate: +35%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −7.0%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 7, FY2019 to FY2025, as filed.

HRMYHarmony Biosciences Holdings, Inc.

HealthcareUSD

$39.64

$25.9052 weeks$40.51

Is it growing?

Is HRMY growing?

Harmony Biosciences Holdings, Inc. has grown revenue 24% a year over three years and 35% a year over five, with earnings per share compounding at −7.0%.

+24%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +35%
Revenue growth, 5-year rate · +24% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −7.0%
Earnings per share, 3-year rate · revenue +24% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed